FACTORS INFLUENCING THE SOCIAL ADAPTATION OF CAREGIVERS OF PATIENTS WITH THE ADVANCED AND END STAGES OF PARKINSON’S DISEASE

O. S. Zimnyakova; Zh. M. Glozman; O. S. Levin

doi:10.17816/rmj37974

Russian Medicine ›› 2012, Vol. 18 ›› Issue (3) : 14 -17. DOI: 10.17816/rmj37974

Articles

research-article

FACTORS INFLUENCING THE SOCIAL ADAPTATION OF CAREGIVERS OF PATIENTS WITH THE ADVANCED AND END STAGES OF PARKINSON’S DISEASE

Author information +

History +

PDF

Abstract

The status of caregivers of patients with the end and advanced stages of Parkinson’s disease (PD) has been poorly studied. The aim of the study was to investigate the factors influencing the social adaptation of caregivers. The scale of social adaptation (Zh. M. Glozman, 1998) was used to estimate its level. The Unified PD Rating Scale, Schwab and England Activities of Daily Living scale, Barthel index, Autonomic Impairment Scale, Addenbrooke’s Cognitive Examination, Cornell Scale for Depression in Dementia, and Neuropsychiatric Inventory were used for the clinical evaluation of the patients’ state. The main determinants of the social adaptation of caregivers were professional, family-domestic, and leisure limitations and emotional changes, which were determined by the severity of symptoms of parkinsonism, particularly axial motor impairments and psychotic, autonomic, and cognitive disorders in patients with PD.

Keywords

Parkinson’s disease / caregivers’ social adaptation / cognitive impairments / neuropsychiatric impairments

Cite this article

Download citation ▾

O. S. Zimnyakova, Zh. M. Glozman, O. S. Levin. FACTORS INFLUENCING THE SOCIAL ADAPTATION OF CAREGIVERS OF PATIENTS WITH THE ADVANCED AND END STAGES OF PARKINSON’S DISEASE. Russian Medicine, 2012, 18(3): 14-17 DOI:10.17816/rmj37974

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Глозман Ж. М. // Вестник Моск. ун-та. Сер. 14: Психология. — 1990. — № 1. — С. 13—14.

[2]	Глозман Ж. М., Бичева К. Г., Федорова Н. В. // Вестн. Моск. унта. Сер. 14: Психология. — 1998. — № 3. — С. 63—71.

[3]	Глозман Ж. М., Левин О. С. // Экстрапирамидные расстройства. Руководство по диагностике и лечению / Под ред. В. Н. Штока и др. — М.: Медпресс-информ, 2002. — С. 56—73.

[4]	Левин О. С., Наймушина Т. В., Смоленцева И. Г. // Неврол. журн. — 2002. — № 5. — С. 21—28.

[5]	Левин О. С., Иванов А. К., Батукаева Л. А., Махнев С. О. // Рос. мед. журн. — 2009. — № 6. — С. 52—56.

[6]	Aarsland D., Larsen J. P., Karlsen K. et al. // Int. J. Geriatr. Psychiatry. — 1999. — Vol. 14. — P. 866—874.

[7]	Aarsland D., Larsen J. P., Lim N. G. et al. // J. Neurol. Neurosurg. Psychiatry. — 1999. — Vol. 67. — P. 492—496.

[8]	Caap-Ahlgren M., Dehlin O. // Aging Clin. Exp. Res. — 2002. — Vol. 14. — P. 371—377.

[9]	Carrois F. // Novartis Pharma. — 2001. — URL: http://www.proximo logie.com.

[10]	Carter J. H., Stewart B. J., Lyons K. S., Archbold P. G. // Mov. Disord. — 2008. — Vol. 23. — P. 1211—1216.

[11]	Cummings J. L., Mega M., Gray K. et al. // Neurology. — 1994. — Vol. 44. — P. 2308—2314.

[12]	Duvoisin R. C. Parkinson's disease: a guide for patients and family. — New York: Raven Press, 1984.

[13]	Edwards N. E., Scheetz P. S. // J. Neurosci. Nurs. — 2002. — Vol. 34. — P. 184—190.

[14]	Ellgring H., Seiler S., Perleth B. et al. // Neurology. — 1993. — Vol. 43 (supll.). — P. 41—44.

[15]	Fahn S., Elton R. // Recent developments in Parkinson's disease / Eds S. Fahn et al. — New Jersey: Florham Park, 1987. — P. 153— 163; 293—304.

[16]	Fahn S., Elton R., Gallo J. J. // J. Family Pract. — 1990. — Vol. 30, N 4. — P. 430—436.

[17]	Gallo J. J. // J. Family Pract. — 1990. — Vol. 30, N 4. — P. 437—440.

[18]	Gelb D. J., Oliver E., Gilman S. // Arch. Neurol. — 1999. — Vol. 56. — P. 33—39.

[19]	Gibb W. R., Less A. J. // J. Neurol. Neurosurg. Psychiatry. — 1988. — Vol. 51. — P. 745—752.

[20]	Hoehn M. M., Yahr M. D. // Neurology — 1967. — Vol. 17. — P. 427—442.

[21]	Kaufer D. I., Cummings J. L., Christine D. et al. // J. Am. Geriatr. Soc. — 1998. — Vol. 46. — P. 210—215.

[22]	Kinsella G., Duffy E. // Lebrun G., Hoops R. The management of aphasia. — 1978. — Vol. 4. — P. 26—28.

[23]	Lokk J. // Eur. J. Phys. Rehabil. Med. — 2008. — Vol. 44. — P. 39—45.

[24]	Machoney F., Barthel D. Functional evalution: the Barthel Index. Maryland State Med. J. — 1965. — Vol. 14. — P. 61—65.

[25]	Martinez-Martin P., Benito-Leon J., Alonso F. et al. // Qual. Life Res. — 2005. — Vol. 14. — P. 463—472.

[26]	Mioshi E., Dawson K., Mitchell J. et al. // Int. J. Geriatr. Psychiatry. — 2006. — Vol. 21. — P. 1078—1085.

[27]	Schrag A., Hovris A., Morley D. et al. // Parkinsonism Relat. Disord. — 2006. — Vol. 12. — P. 35—41.

[28]	Schwab R. S., England A. L. // Third symposium on Parkinson's disease / Eds F. H. Billingham, M. C. Donaldson. — Edinburgh, 1969. — P. 152—157.